This article is more than 5 years old. Information may no longer be current.

FDA clears Zepto capsulotomy system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA has granted 510(k) clearance for the Zepto capsulotomy system from Mynosys Cellular Devices for lens capsulotomy during cataract surgery, according to a press release.

The Zepto system, named for the metric unit of measurement 1 million times smaller than femto, can be used through a 2.2-mm incision. Its design allows it to be used in traditional cataract surgery, as well as in challenging cases such as small pupils, zonulopathies, corneal opacities and intumescent cataracts, the release said.

“We have seen a very broad and deep demand for an automated capsulotomy product such as Zepto that is easy to use, disposable, inexpensive and consistently gives a great outcome,” John Hendrick, CEO of Mynosys, said in the release.